News
All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...
Speaking at BIO 2025, Makary bemoaned what he called “unnecessary steps” and “avoidable delays” in the U.S. regulatory ...
FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.
Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...
Vinay Prasad, the FDA’s freshly appointed head of vaccines, has been named chief medical and scientific officer, taking on ...
US regulators, under the guidance of FDA Commissioner Marty Makary, are launching a program to accelerate drug approvals, ...
According to an internal email, the agency may be in for more consolidation in areas including human resources, ...
FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...
Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after a recent study raised concerns about medical side effects.
23h
Pharmaceutical Technology on MSNFDA Commissioner envisions fewer delays, more clinical trial flexibility and AI useFDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results